
via drugtargetreview.com
A group of researchers has found a new way to limit excessive immune responses, which may point in a new direction for research in and treatment of e.g. autoimmune diseases.
Researchers from Aarhus University Hospital and Aarhus University in Denmark in collaboration with researchers from Colorado in the United States have found a new way to treat the inflammation involved in chronic diseases such as psoriasis, asthma and HIV. A group of transmitter substances (cytokines) in the immune system, the so-called IL-1 family, has been shown to play an important role in many of these diseases by regulating the body’s immune responses.
Professor Charles A. Dinarello from University of Colorado Denver is also an honorary doctor at Aarhus University. He is an expert in regulation and transmission of these cytokines. He is primarily known for discovering the important cytokine IL-1(-?), which plays an important role in countless diseases. In collaboration with Charles Dinarello, the Danish researchers have investigated a more efficient way of reducing the effect of the IL-1 family and in this way improve treatment of chronic inflammatory diseases.
Previous research has often focused on blocking a single cytokine or signaling pathway at a time. However, many diseases and sequela are driven by more than one cytokine. This has caused researchers to wonder if it could be possible to block more important signaling pathways of the IL-1 family at the same time, and in this way make it possible to develop better treatments. The researchers try to find a broader anti-inflammatory treatment impacting several important cytokines at the same time, but also trying to avoid that this causes unintended side-effects.
In this study, the researchers have investigated if a receptor (IL-1R3), which is not just involved in the signaling of one but six different inflammatory cytokines in the IL-1 family, could be a possible target in the treatment of chronic inflammatory disease. Using an antibody to block the effect of IL-1R3, it was possible for the researchers to investigate the effects in both studies on cells and mice.
In this way, researchers could study some of the consequences of the blocking of this receptor on the immune system. At the same time, the researchers specifically studied the effect of blocking IL-1R3 in mice with either gout, acute allergic inflammation (asthma) or psoriasis.
– The experiments showed that it was possible to effectively block the receptor and reduce manifestation of diseases, which underlines the potentials in our new approach, says MD and PhD Jesper Falkesgaard Højen.
– Even though new questions arise as a consequences of these results, we have managed to describe a new and effective approach to block IL-1 family driven inflammation, and in this way we have possibly contributed with a new direction to study and treat chronic inflammatory conditions driven by the IL-1 family.
Learn more: Danish-American research presents new ways of developing treatment of chronic inflammation
The Latest on: Autoimmune diseases
[google_news title=”” keyword=”autoimmune diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Autoimmune diseases
- Why Is Vitiligo Considered An Autoimmune Disease? A Review By Doctorson December 7, 2023 at 1:28 pm
Expert opinion from Mohan P. Abraham M.D., FAAFP (Family Physician) · 40 years of experience · USA The body's defense system sometimes malfunction and attacks the healthy cells, this is known as ...
- ANU research uncovers protein's role in autoimmune disease and canceron December 7, 2023 at 9:35 am
A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases such as irritable bowel disease ...
- Global Autoimmune Disease Diagnosis Market Overview, Competitive Analysis and Forecast 2031on December 7, 2023 at 12:27 am
The Autoimmune Disease Diagnosis report examines market segmentation forecasts by product, by test type, by disease, by end user and by region. This report offers thorough information on the ...
- Turning Mutated Protein on and off May Help against Cancer and Autoimmune Diseaseon December 6, 2023 at 6:30 pm
A protein called DECTIN-1 may be responsible for exacerbating the severity of certain autoimmune diseases and cancer.
- Fungus-fighting protein could help overcome severe autoimmune disease and canceron December 6, 2023 at 11:00 am
A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases such as irritable bowel disease ...
- IGM Biosciences Increases Focus On Autoimmune Diseases, Stops All Blood Cancer-Related Studieson December 6, 2023 at 8:09 am
IGM Biosciences Inc (NASDAQ: IGMS) said it will focus on two strategic areas: treating colorectal cancer using IgM death receptor 5 (DR5) agonist antibodies and treating autoimmune diseases using IgM ...
- Expert Shares How Ginger Supplements May Help Manage Symptoms Of Autoimmune Diseases Like Lupuson December 6, 2023 at 7:33 am
Autoimmune diseases are diseases caused due to one’s own immune system attacking their own body tissues and organs. Several autoimmune conditions like rheumatoid arthritis, antiphospholipid syndrome, ...
- CRISPR Therapeutics' Gene-Edited Oncology Pipeline To Focus On Expanded Use In Autoimmune Diseaseson December 5, 2023 at 5:47 am
CRISPR Therapeutics AG (NASDAQ: CRSP) provided an update on its immuno-oncology pipeline of CRISPR/Cas9 gene-edited allogeneic chimeric antigen receptor (CAR) T ...
- CRISPR eyes autoimmune disease in revamp of cell therapy planson December 5, 2023 at 1:10 am
The gene editing biotech is shelving two of its most advanced cancer drugs, and joining a growing group of companies exploring cell-based medicines for inflammatory diseases like lupus.
- Novel Immunotherapy Strategy for Autoimmune Diseaseon December 3, 2023 at 10:40 am
Researchers found that by targeting distinct mechanisms of immune cells, they could selectively eliminate "problematic cells" and reshape the skin's immune landscape.
via Bing News